Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is a disorder caused by clonal proliferation of CD1a(+)/CD207(+) cells and characterized by varying degrees of organ involvement. Treatment of LCH is risk adapted; patients with multisystem disease and risk-organ involvement require more intensive therapy. Optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yaozhu, Xi, Rui, Wang, Cunbang, Fang, Lei, Bai, Jiaofeng, Cai, Yonggang, Guo, Min, Qiao, Ruiyun, Lan, Xu, Yin, Jiaojiao, Yang, Ke, Bai, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753533/
https://www.ncbi.nlm.nih.gov/pubmed/31426694
http://dx.doi.org/10.1177/0300060519864807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753533/
https://www.ncbi.nlm.nih.gov/pubmed/31426694
http://dx.doi.org/10.1177/0300060519864807

Ejemplares similares